Atrial fibrillation and electrical remodeling: The potential role of inflammation and oxidative stress

Medical Science Monitor

Volumn 9, Issue 9, 2003, Pages

  Korantzopoulos, Panagiotis ^a,b   Kolettis, Theofilos ^b   Siogas, Kostas ^a   Goudevenos, John ^b  

^a G HATZIKOSTA GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Antioxidants; Atrial fibrillation; C reactive protein; Electrical remodeling; Inflammation; Oxidative stress

Indexed keywords

ANTIARRHYTHMIC AGENT; ASCORBIC ACID; C REACTIVE PROTEIN; CALCIUM CHANNEL L TYPE; VERAPAMIL;

CALCIUM CELL LEVEL; CARDIOVERSION; CLINICAL TRIAL; ELECTROPHYSIOLOGY; HEART ATRIUM CONDUCTION; HEART ATRIUM FIBRILLATION; HEART MUSCLE CELL; HUMAN; INCIDENCE; INFLAMMATION; OXIDATIVE STRESS; PROGNOSIS; RECURRENT DISEASE; REVIEW; SIDE EFFECT;

ACTION POTENTIALS; ANIMALS; ATRIAL FIBRILLATION; ATRIAL FUNCTION; CALCIUM CHANNELS, L-TYPE; ELECTROPHYSIOLOGY; HUMANS; INFLAMMATION; OXIDATIVE STRESS;

EID: 18144452754     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Tsang TSM, Gersh BJ: Atrial fibrillation: An old disease, a new epidemic. Am J Med, 2002; 113: 432-435
2. Mitchell AR: Atrial fibrillation in the new millennium - the role of pacemaker and defibrillator therapy. Med Sci Monit, 2002; 8: RA233-239
3. Chung SS, Blackshear JL, Shen WK et al: Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol, 2001; 37: 371-378
4. nd ed, Philadelphia, Lippincott Williams & Wilkins, 2001; 457-499
5. Goudevenos JA, Vakalis JN, Giogiakas V et al: An epidemiological study of symptomatic paroxysmal atrial fibrillation in northwest Greece. Europace, 1999; 1: 226-233
6. Benjamin EJ, Wolf PA, D'Agostino RB et al: Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation, 1998; 98: 946-952
7. Moe GK, Rheinboldt WB, Abildskov JA: A computer model of atrial fibrillation. Am Heart J, 1964; 67: 200-220
8. Allessie MA, Lammers WJEP, Bonke FIM, Hollen J: Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation. In: Zipes DP, Jalife J (eds). Cardiac Electrophysiology and Arrhythmias. Grune & Stratton Inc, Orlando, 1985; 265-275
9. Nattel S: New ideas about atrial fibrillation 50 years on. Nature, 2002; 415: 219-226
10. Frame HL: Lessons from animal models of atrial arrhythmias. Cardiol Clin, 1996; 14: 483-505
11. Tse HF, Lau CP: Electrophysiological properties of the fibrillating atrium: implications for therapy. Clin Exp Pharmacol Physiol, 1998; 25: 293-302
12. Fuster V, Ryden LE, Asinger RW et al: ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur Heart J, 2001; 22: 1852-1923
13. Kosior D, Opolski G, Torbicki A: Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation. Med Sci Monit, 2001; 7: 68-73
14. Wijffels MC, Kirchoff CJ, Dorland R, Allessie MA: Arial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation, 1995; 92: 1954-1968
15. Nattel S, Li D, Yue L: Basic mechanisms of atrial fibrillation: very new insights into very old ideas. Annu Rev Physiol, 2000; 62: 51-77
16. Franz MR, Kapasik PL, Li C et al: Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter. J Am Coll Cardiol, 1997; 30: 1785-1792
17. van Wagoner DR, Nerbonne JM: Molecular basis of electrical remodeling in atrial fibrillation. J Moll Cell Cardiol, 2000; 32: 1101-1117
18. Allessie M, Ausma J, Schotten U: Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res, 2002; 54: 230-246
19. Nattel S: Atrial electrophysiological remodeling caused by rapid atrial activation: underlying mechanisms and clinical relevance to atrial fibrillation. Cardiovasc Res. 1999; 49: 298-308
20. Allessie MA, Borden PA, Camm AJ et al: Pathophysiology and prevention of atrial fibrillation. Circulation, 2001; 103: 769-777
21. Manios EG, Kanoupakis EM, Chlouverakis GI et al: Changes in atrial electrical properties following cardioversion of chronic atrial fibrillation: relation with recurrence. Cardiovasc Res, 2000; 47: 244-253
22. Pandozi C, Bianconi L, Villani M et al: Electrophysiological characteristics of the human atria after cardioversion of persistent atrial fibrillation. Circulation, 1998; 98: 2860-2865
23. Tieleman RG, van Gelder IC, Crijns HJGM et al: Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol, 1998; 31: 167-173
24. Yu WC, Lee SH, Tai CT et al: Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man. Cardiovasc Res, 1999; 42: 470-476
25. Hobbs WJC, Fynn S, Todd DM et al: Reversal of atrial electrical remodeling after cardioversion of persistent atrial fibrillation in humans. Circulation, 2000; 101: 1145-1151
26. Bruins P, te Velthuis H, Yazdanbakhsh AP et al: Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation, 1997; 96: 3542-3548
27. Maisel WH, Rawn JD, Stevenson WG: Atrial fibrillation after cardiac surgery. Ann Intern Med, 2001; 135: 1061-1073
28. Soucier R, Silverman D, Abordo M et al: Propafenone versus ibutilide for post operative atrial fibrillation following cardiac surgery: neither strategy improves outcomes compared to rate control alone (the PIPAF study). Med Sci Monit, 2003; 9: P119-23
29. Frustaci A, Chimenti C, Bellocci F et al: Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation, 1997; 96: 1180-1184
30. Dernellis J, Panaretou M: C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation. Acta Cardiol, 2001; 56: 375-380
31. Chung MK, Martin DO, Sprecher D et al: C-reactive protein evaluation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation, 2001; 104: 2886-2891
32. Acevedo M, Corbalan RL, Perez L et al: C-reactive protein in atrial fibrillation: evidence for the presence of inflammation in the genesis and perpetuation of the arrhythmia. (Abstr.) J Am Coll Cardiol, 2003; 41 (Suppl. A): 99A, 1089-14
33. Asselbergs FW, Diercks GF, van den Berg MP et al: C-reactive protein and microalbuminuria are associated with atrial fibrillation. (Abstr.) J Am Coll Cardiol, 2003; 41(Suppl. A): 99A, 1089-16
34. Wazni O, Marrouche NF, Martin D et al: Highly sensitive C-reactive protein level predicts recurrence of atrial fibrillation after cardioversion in patients on antiarrhythmic drugs. (Abstr.) J Am Coll Cardiol, 2003; 41(Suppl. A): 85A, 1015-18
35. Parakh K, Murray RD, Thambidorai SK et al: C-reactive protein is associated with transesophageal markers of thromboembolic risk in patients with atrial fibrillation. (Abstr.) Circulation, 2002; 106(Suppl. II): 11-560, 2767
36. Maycock CAA, Lappe DL, Crandall BG et al: Is atrial fibrillation an inflammatory disease reflected by elevated C-rective protein? (Abstr.) J Am Coll Cardiol, 2003; 41(Suppl. A): 99A, 1089-17
37. Korantzopoulos P, Galaris D, Papaioannides D, Kokkoris S: C-reactive protein and oxidative stress in atrial fibrillation. Int J Cardiol, 2003; 88: 103-104
38. Mihm MJ, Yu F, Carnes CA et al: Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation, 2001; 104: 174-180
39. Carnes CA, Chung MK, Nakayama T et al: Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res, 2001; 89: e32-38
40. Dhalla NS, Temsah RM, Netticadan T: Role of oxidative stress in cardiovascular diseases. J Hypertens, 2000; 18: 655-673
41. Halliwell B, Gutteridge JMC: Free radicals in biology and medicine, 3rd ed. Oxford: Oxford University Press, 1999
42. Korantzopoulos P, Papaioannides D, Galaris D, Kokkoris S: Does C-reactive protein represent an oxidative stress marker in cardiovascular disease? Int J Clin Pract, 2003; 57: 252